Using a carefully orchestrated algorithm based on likes, shares, comments and unabashed personal interest, here are our top tweets so far.
Using a carefully orchestrated algorithm based on likes, shares, comments and unabashed personal interest, here are our top tweets so far.
On a day like this, there’s no better place to be than safely inside the conference hall.
Gloomy Philly 🌧 #ACR22 pic.twitter.com/RObJi81Oq0
— Herman Tam (@DrPedsRheum) November 11, 2022
.
Rheumatology meets poetry in the most popular tweet of the day.
Tanka Name the Syndrome#medtwitter #MedicineinBrief#ACR22
— Cynthia Cooper (@DrCindyCooper) November 11, 2022
Hives, sore joints flare out
Fever, chills recurrent bouts
Hearing grows more faint
Cryopyrin from parent
Clogged tissues proteins errant pic.twitter.com/PL2nke7nvA
.
Kicking off the Review course was the Sjogren’s mimics presentation, one of the big hits from the session.
Not all dry eyes and mouth is due to Sjogren’s syndrome (SS). Think of mimics including diabetes, HCV, HIV, sarcoidosis.
— Dr. Antoni Chan (@synovialjoints) November 11, 2022
Equally, not all parotid enlargement is due to SS. Think of mimics including IgG4, sialodenosis #ReviewCourse @RheumNow #ACR22 pic.twitter.com/zPwRRtdGjT
Listen as Rheumatology Republic ACR22 podcaster Dr Julian Segan caught up with Dr Laura Eades afterwards.
.
Wrapping up the Review course was Dr Daniel Kastner’s review of autoinflammatory conditions, another hit session.
Great review of autoinflammatory conditions by Dr. Daniel Kastner!#ACR22 @ACRheum #RheumTwitter pic.twitter.com/28yFKcD9iE
— Pegah Jahangiri, M.D. (@DrHeliumm) November 11, 2022
.
Pathogenesis of lupus and treatment targets: an artwork
✅ Let’s get ready for #ACR22 with an updated slide for the pathogenesis of systemic #Lupus.
— Laurent ARNAUD (@Lupusreference) November 10, 2022
I have added all new #treatment targets 🎯 presented at the conference 👍 Please let me know if you think I should add something else 🙏 Feel free to reuse ♻️ #Rheumtwitter #Medtwitter pic.twitter.com/sEJNos5JDL
.
Going back to basics – good old MTX in PsA
Methotrexate (MTX) works in early PsA. Confirms what we see in clinical practice
— Dr. Antoni Chan (@synovialjoints) November 11, 2022
◦ Mean disease duration 0.6y
◦ bDMARD naive
◦ MTX monotherapy
➢ ACR20 50.7%
➢ ACR50 30.6%
➢ MDA 22.9%
Good to know, our trusted friend MTX works
Jose Scher #ReviewCourse @RheumNow #ACR22 pic.twitter.com/ECyM4qtliG
.
The question on the lips of many:
As we tweet away at #ACR22 , we watch the erosion of Twitter. This platform has been so amazing for #MedEd Where do you think the best place is for us to migrate eventually? I don’t want to lose this virtual community #RheumTwitter #MedTwitter
— Marie Kuchynski MD (@Doctorkuch) November 12, 2022
.
Rheumatology Republic’s Top Tweets just wouldn’t be the same without at least one food-related tweet. Let’s kick off with the Doctors Calabrese:
First stop #ACR22 @LCalabreseDO . Whats everyone noshing on today? pic.twitter.com/bqWwws2iaH
— Cassandra Calabrese (@CCalabreseDO) November 10, 2022
.
And since you asked for it, another food one:
Anyone want to revive #ACRDonutChallenge? #ACR22 pic.twitter.com/y4bJriZYrO
— Elizabeth Graef (@SituationRheum) November 11, 2022
